ARTICLE | Clinical News
Hybrigenics preclinical data
November 14, 2011 8:00 AM UTC
In vitro, HBX 19,818 significantly reduced the cell number of all CLL primary cell lines and cultures at concentrations that did not significantly affect the viability of control non-tumor peripheral ...